PreMD shares soar on AstraZeneca deal

(Reuters) - TORONTO, July 16 - Shares of PreMD jumped more than 50 percent on Monday after the small Canadian biotechnology company signed a U.S. marketing deal with AstraZeneca Pharmaceuticals LP for its skin cholesterol test.



PreMD shares were up 60 Canadian cents, or 52.2 percent, at C$1.75 at midmorning on the Toronto Stock Exchange.


Read more at Reuters.com Hot Stocks News

UPDATE 2-Chinalco to buy Peru Copper for C$840 mln

(Reuters) - The offer of C$6.60 a share is a 21 percent premium to Peru
Copper's 20-day volume weighted average price of C$5.45 on the
Toronto Stock Exchange ended May 23.




The company's shares were up 10 Canadian cents at C$6.45
after the announcement on Monday.


Read more at Reuters.com Mergers News